本页面由Tiger Trade Technology Pte. Ltd.提供服务

Impel NeuroPharma, Inc.

0.0400
0.0000
成交量:- -
成交额:- -
市值:- -
市盈率:-0.01
高:0.0400
开:0.0400
低:0.0400
收:0.0400
52周最高:0.0400
52周最低:0.0400
股本:- -
流通股本:- -
量比:0.99
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.1280
每股收益(LYR):-4.5345
净资产收益率:-2546.09%
总资产收益率:-62.49%
市净率:0.00
市盈率(LYR):-0.01

数据加载中...

2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/14

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/14

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/27

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/18

重要事件披露

Form 8-K - Current report
2023/12/04

重要事件披露

Form 8-K - Current report
2023/12/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/10/17

重要事件披露

Form 8-K - Current report
2023/10/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/05

重要事件披露

Form 8-K - Current report
2023/09/19

重要事件披露

Form 8-K - Current report
2023/09/16

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership